-
“
#KrystalBiotech is taking on challenges that others in the market are not.” This is what Pittsburgh does ... an iconic place at the forefront of what’s next.#lifesciences#biotechpic.twitter.com/eApptY6DUc – mjesto: Pittsburgh International Airport (PIT) -
$KRYS#KRYSTALBIOTECH - Daily: KRYSTAL BIOTECH INC. is part of a very strong bullish trend. Traders may consider trading only long positions (at the time of purchase) as long as the price remains well above 40.53 USD. The next resistance located at 46.56… http://dlvr.it/RCbyvp -
Today's
@Reuters article from@HamaraTamara and@CarlODonnell26 highlights#KrystalBiotech as one of 11 companies leading the way by making early investments in#GeneTherapy manufacturing, greatly streamlining the therapy development process. Read it here:https://reut.rs/2XUDEmY -
$KRYS Granted its First Foreign Patent and a New U.S. Patent#KrystalBiotech http://crweworld.com/symbol/KRYS -
Groundbreaking Second Commercial Gene Therapy Manufacturing Facility Announced by Krystal Biotech
#KrystalBiotech - https://biopharma-asia.com/sections/groundbreaking-second-commercial-gene-therapy-manufacturing-facility-announced-by-krystal-biotech/ … -
$KRYS in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://tickeron.com/go/1205712#KrystalBiotech#stockmarket#stock#technicalanalysis#money#trading#investing#daytrading#news#todaypic.twitter.com/9k1TaytioD
-
#Krystalbiotech CEO Krish Krishnan speaks to the crowd about a “groundbreaking” moment tied to big company expansion in Pittsburgh ... manufacturing groundbreaking medicines for patients with rare skin disease.#biotech#lifesciencespic.twitter.com/zJI3WAzbGP
-
Krystal Biotech : Summary ToggleKrystal Biotech Receives Positive EMA Opinion on Orphan De...
#KrystalBiotech#Stock#MarketScreener http://marketscreener.com/KRYSTAL-BIOTECH-INC-37797982/news/Krystal-Biotech-Summary-ToggleKrystal-Biotech-Receives-Positive-EMA-Opinion-on-Orphan-Designation-29361657/ …pic.twitter.com/dUgoaUiFOY
-
$KRYS anticipates commencing Phase 3 KB103 trial before year-end, stock sails +29.50%#KrystalBiotech https://www.newsquantified.com/krys/stock-report/krystal-biotech-inc-anticipates-commencing-phase-3-kb103-06kbk2#app0 … -
#KrystalBiotech Files#IND With#US.#FDA for KB105, Topical#GeneTherapy Candidate for#Transglutaminase-1 Deficient#Autosomal Recessive Congenital#Ichthyosis https://www.trialsitenews.com/krystal-biotech-files-ind-with-u-s-fda-for-kb105-topical-gene-therapy-candidate-for-transglutaminase-1-deficient-autosomal-recessive-congenital-ichthyosis/ … via@Trial Site News#topical#healthcare -
$KRYS receives PRIME eligibility for KB103 from EMA, stock boosts +5.03%#KrystalBiotech https://www.newsquantified.com/krys/stock-report/krystal-biotech-inc-receives-prime-eligibility-for-kb103-06byge#app0 … -
$KRYS shares could rally 30%-50% on data readout claims William Blair, stock inclines +8.48%#KrystalBiotech https://www.newsquantified.com/krys/stock-report/krystal-biotech-inc-shares-could-rally-3050-on-06bu1m#app0 … -
Gene therapy company Krystal Biotech will take the wraps off its initial 4,500-square-foot cGMP manufacturing center this week...Find more at https://aspenxchange.com/
#KrystalBiotech#aspenxchange#aspenalertpic.twitter.com/o6HKabROli
-
$KRYS priced 3M shares of common stock at $20.00/share, stock jumps +7.48%#KrystalBiotech https://hubs.ly/H0fb_q40 -
$KRYS to hold a conference call, stock surges +33.26%,#KrystalBiotech https://hubs.ly/H0f7ct90
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.